Literature DB >> 31162269

18F-PSMA 1007 Brain PET/CT Imaging in Glioma Recurrence.

Fahad Marafi1, Arun Sasikumar2, Wael Fathallah3, Abdulredh Esmail1.   

Abstract

A 64-year-old man with a known case of right parietal lobe glioblastoma multiforme operated on in August 2018 was referred for F-FDG PET/CT with a clinical suspicion of recurrence. He underwent F-FDG and F-PSMA 1007 scans. Both the scans showed intense tracer uptake in right parietal lobe lesion, which concurred with MRI findings of recurrent disease and was later proven on histopathologic examination as recurrence. Our case highlights the feasibility of F-PSMA 1007 PET/CT imaging of suspected glioblastoma recurrence. Considering its similarity to PSMA-617, it may be used as a surrogate imaging tracer for potential theranostic application using alpha or beta emitters.

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 31162269     DOI： 10.1097/RLU.0000000000002668

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN： 0363-9762            Impact factor:   7.794


  13 in total

1.  Ga-68 PSMA PET/CT in recurrent high-grade gliomas: evaluating PSMA expression in vivo.

Authors:  Arunav Kumar; Sreedharan Thankarajan ArunRaj; Khush Bhullar; K P Haresh; Subhash Gupta; Sanjana Ballal; Madhav Yadav; Manmohan Singh; Nishikant Avinash Damle; Ajay Garg; Madhavi Tripathi; Chandrasekhar Bal
Journal:  Neuroradiology       Date:  2021-10-14       Impact factor: 2.804

2.  PSMA Expression in Glioblastoma as a Basis for Theranostic Approaches: A Retrospective, Correlational Panel Study Including Immunohistochemistry, Clinical Parameters and PET Imaging.

Authors:  Adrien Holzgreve; Annamaria Biczok; Viktoria C Ruf; Friederike Liesche-Starnecker; Katja Steiger; Maximilian A Kirchner; Marcus Unterrainer; Lena Mittlmeier; Jochen Herms; Jürgen Schlegel; Peter Bartenstein; Jörg-Christian Tonn; Nathalie L Albert; Bogdana Suchorska
Journal:  Front Oncol       Date:  2021-03-30       Impact factor: 6.244

3.  Non-prostate uptake on 18F-PSMA-1007 PET/CT: a case of myeloma.

Authors:  Sowmya Veerasuri; Stewart Redman; Richard Graham; Chris Meehan; David Little
Journal:  BJR Case Rep       Date:  2020-11-03

4.  Expression of glutamate carboxypeptidase II in the glial tumor recurrence evaluated in vivo using radionuclide imaging.

Authors:  Jolanta Kunikowska; Rafał Czepczyński; Dariusz Pawlak; Henryk Koziara; Kacper Pełka; Leszek Królicki
Journal:  Sci Rep       Date:  2022-01-13       Impact factor: 4.379

5.  PSMA Theranostics: Is the Time Ripe to Pave the Way to Further Tumor Entities?

Authors:  Winfried Brenner; Joachim Strobel; Vikas Prasad
Journal:  J Nucl Med       Date:  2021-07-16       Impact factor: 10.057

6.  Tumor uptake in glioblastoma multiforme after IV injection of [177Lu]Lu-PSMA-617.

Authors:  Jolanta Kunikowska; Ingeborga Charzyńska; Radosław Kuliński; Dariusz Pawlak; Michał Maurin; Leszek Królicki
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-02-10       Impact factor: 9.236

7.  Potential of Radiolabeled PSMA PET/CT or PET/MRI Diagnostic Procedures in Gliomas/Glioblastomas.

Authors:  Francesco Bertagna; Domenico Albano; Elisabetta Cerudelli; Maria Gazzilli; Raffaele Giubbini; Giorgio Treglia
Journal:  Curr Radiopharm       Date:  2020

Review 8.  Molecular and Cellular Complexity of Glioma. Focus on Tumour Microenvironment and the Use of Molecular and Imaging Biomarkers to Overcome Treatment Resistance.

Authors:  Silvia Valtorta; Daniela Salvatore; Paolo Rainone; Sara Belloli; Gloria Bertoli; Rosa Maria Moresco
Journal:  Int J Mol Sci       Date:  2020-08-06       Impact factor: 5.923

Review 9.  A perspective on the radiopharmaceutical requirements for imaging and therapy of glioblastoma.

Authors:  Julie Bolcaen; Janke Kleynhans; Shankari Nair; Jeroen Verhoeven; Ingeborg Goethals; Mike Sathekge; Charlot Vandevoorde; Thomas Ebenhan
Journal:  Theranostics       Date:  2021-07-06       Impact factor: 11.556

10.  Duodenal Adenocarcinoma Mimicking Metastasis of Prostate Cancer on 18F-Prostate-Specific Membrane Antigen-1007 PET/CT.

Authors:  Fumihiko Soeda; Tadashi Watabe; Hiroki Kato; Motohide Uemura; Norio Nonomura
Journal:  Clin Nucl Med       Date:  2021-01       Impact factor: 10.782
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.